Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1167557 Greenwich, CT
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,021,421
+$534,288 QoQ
Shares Held
158,511
+2.7% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 254 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. PCRX ranks #27 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in PCRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,021,421 158,511
2026-03-31 $3,487,133 154,298
2025-12-31 $3,551,589 137,233
2025-09-30 $3,618,132 140,401
2025-06-30 $3,397,693 142,163
2025-03-31 $4,393,055 176,783
2024-12-31 $5,435,321 288,499
2024-09-30 $8,220,429 546,208
2024-06-30 $1,934,407 67,613
2024-03-31 $1,802,727 61,695
2023-12-31 $4,817,194 142,774
2023-09-30 $3,338,628 108,821
2023-06-30 $1,633,253 40,760
2023-03-31 $1,186,101 29,064
2021-03-31 $551,398 7,867
2020-12-31 $942,120 15,744
2020-09-30 $1,125,386 18,719
2020-06-30 $2,619,092 49,916
2020-03-31 $1,784,164 53,211